• Profile
Close

Outcomes of febrile events in pediatric patients with sickle cell anemia

Pediatric Blood & Cancer Aug 06, 2018

Sirigaddi K, et al. - Via a 16-year retrospective study, researchers assessed bacteremia outcomes for febrile sickle cell patients and analyzed risk variables including fever (either ≥ 39.5°C or ≥ 40°C), abnormal white blood cell (WBC) (>30,000 or <5,000/mcL), tachycardia, hypotension, or “ill appearing.” Analyzing 14-day readmission rates, they assessed outcomes for febrile sickle cell patients discharged from the emergency department (ED) or discharged within 72 hours. In this study, admission criteria developed using WBC count, hypotension, and “ill appearance” showed the highest sensitivity and specificity for identifying bacteremia. Discharge at 48 hours can be considered for persistently febrile, well-appearing patient, with minimal risk for new complications.

Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay